Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research



Escherichia coli Isolated from Horses and Study the Effect of the Peganum harmaline Extract In Vitro and In Vivo and Antibiofilm Effect In Vitro

Aseel Mohammed Hamzah.

Abstract
Out of a hundred horses, fecal samples Escherichia coli was isolated from 37 samples of different ages, The isolated samples had been used to examine the effect of peganum harmaline on isolated E.coli in vitro and in vivo.
The goal of this research was to determine the antimicrobial activity of peganum harmaline extract by means of (ethanol: methanol 1:1) in opposition to Escherichia coli at various 40,20, 10, 5, 2,5, 1,25 and 0,625 mg/ml concentrations in each plastic and glass tube. The values of MIC (minimum inhibitory concentration) and MBC (minimum bactericidal concentration) for the extract against E.coli were equal to (0.625 mg/ml) for MIC and (10 mg/ml) for MBC on bacteria which cultured on glass tube while the MIC value was 40 mg/ml and MBC was10 mg/ml on plastic tube. The effect of Peganum harmaline on the formation of E.coli biofilm was investigated and the biofilm inhibitory concentrations were 40-6.25mg / ml in vitro. In vivo, a group of laboratory mice used, the LD50 of peganum harmaline extract was tested orally by up and down method and found to be 1030 mg/kg body weight, the extract used as 103 mg/kg bodyweight treatment after causing E.coli infection at 1108 CFU/ml in laboratory mice the treated persist for two weeks in group one and three weeks in the second group as well as three week treated in the third group from the second days after infection while the control group left without treated and the mice sacrificed after second, third and fifth days of infection. The result shows histopathological changes in all treated groups, especially in the third group and that refers to the antibacterial effect of the peganum harmaline ethanolic extract when compared to the infected control group.

Key words: Escherichia coli, peganum harmaline, antibacterial, antibiofilm, LD50, histopathological lesion.



Similar Articles

Chitosan-based hydrogels with injectable, self-healing and antibacterial properties for wound healing.
Deng P, Yao L, Chen J, Tang Z, Zhou J
Carbohydrate polymers. 2022; 276(): 118718

Stretchable unidirectional liquid-transporting membrane with antibacterial and biocompatible features based on chitosan derivative and composite nanofibers.
Li L, Mai Y, Wang Y, Chen S
Carbohydrate polymers. 2022; 276(): 118703

Versatile antibacterial surface with amphiphilic quaternized chitin-based derivatives for catheter associated infection prevention.
Xie F, Bian X, Lu Y, Xia T, Xu D, Wang Y, Cai J
Carbohydrate polymers. 2022; 275(): 118683

Delivery of Double-Stranded RNAs (dsRNAs) Produced by Escherichia coli HT115(DE3) for Nontransgenic RNAi-Based Insect Pest Management.
Taracena ML, Garcia Caffaro I, Paiva-Silva GO, Oliveira PL, Rendon PA, Dotson EM, Pennington PM
Methods in molecular biology (Clifton, N.J.). 2022; 2360(): 279-294

Baicalin-liposomes loaded polyvinyl alcohol-chitosan electrospinning nanofibrous films: Characterization, antibacterial properties and preservation effects on mushrooms.
Lu S, Tao J, Liu X, Wen Z
Food chemistry. 2022; 371(): 131372


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites